Melanocortins and Interleukins Contributing to Advanced Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in Patients With BMI ≥ 40

被引：0
|
作者：
Baranova, Ancha
Jarrar, Mohammed
Moazzez, Amir H.
Elariny, Hazem
Abawi, Massih
Wang, Lei
Afendy, Arian
Stepanova, Maria
Estep, J. M.
Younossi, Zobair M.
机构：
来源：
OBESITY | 2011年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S87 / S87
页数：1
相关论文
共 50 条
  • [21] A single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Otgonsuren, Munkhzul
    Estep, Michael J.
    Hossain, Nayeem
    Younossi, Elena
    Frost, Spencer
    Henry, Linda
    Hunt, Sharon
    Fang, Yun
    Goodman, Zachary
    Younossi, Zobair M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (12) : 2006 - 2013
  • [22] Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
    Tacke, Frank
    Weiskirchen, Ralf
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [23] Liver stiffness measurement using transient elastography in patients with non-alcoholic fatty liver (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Miette, Veronique
    Fournier, Celine
    Adara, Linda
    Sandrin, Laurent
    2007 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1-6, 2007, : 1333 - 1336
  • [24] Nicht alkoholische Fettleberkrankheit (NAFLK) Steatosis hepatis — NASH Non-alcoholic fatty liver disease (NAFLD) Non-alcoholic steatohepatitis − NASH
    K.-M. Keller
    Monatsschrift Kinderheilkunde, 2004, 152 : 864 - 869
  • [25] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV
    Verna, Elizabeth C.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (03): : 211 - 223
  • [26] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [27] The Serum Biomarkers of Cardiovascular Disease Are Elevated in Patients With Non-alcoholic Fatty Liver Disease (NAFLD) With Advanced Fibrosis and Histologically-Proven Non-alcoholic Steatohepatitis (NASH)
    Elsheikh, Elzafir
    Tran, Henry A.
    Karrar, Azza
    Estep, Michael
    Felix, Sean C.
    Jeffers, Thomas
    Younoszai, Zahra
    Racila, Andrei
    Fang, Yun
    Elsheikh, Munkhzul
    Lam, Brian P.
    Abdul-Al, Hala
    Goodman, Zachary
    Gerber, Lynn
    Younossi, Zobair M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S538 - S539
  • [28] Non-alcoholic fatty liver disease (NAFLD) after orthotopic liver transplantation (OLT) in patients with cryptogenic cirrhosis (CC) and non-alcoholic steatohepatitis (NASH)
    Amaro, R
    Montalbano, M
    Acosta, RC
    Concha, R
    Weppler, D
    Neff, GW
    O'Brien, CB
    Molina, EG
    Schiff, ER
    Tzakis, AG
    GASTROENTEROLOGY, 2001, 120 (05) : A118 - A118
  • [29] LDL:HDL Ratio as a Risk Factor for Non-Alcoholic Steatohepatitis (NASH) in Non-Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients
    Mitchell, Brittany
    Aggarwal, Manik
    McCullough, Arthur
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S544 - S545
  • [30] HLA Class II Alleles Are Strongly Associated with Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Fibrosis
    Karrar, Azza
    Li, Zheng
    Moosvi, Ali M.
    Hariharan, Siddharth
    Fang, Yun
    Stepanova, Maria
    Goodman, Zachary D.
    Younossi, Zobair
    HEPATOLOGY, 2014, 60 : 601A - 602A
12345